Converting to daily morphine equivalents is not elementary. Inaccurate opioid conversions can place patients at increased risk of underdose or overdose. A recent petition to the Food and Drug Administration (FDA) filed in July 2012 requesting that the FDA change labeling on opioid analgesics to restrict daily dosing for non-cancer pain to a maximum of 100mg morphine or its equivalent was rejected due to lack of validated data to support a single conversion strategy.
In consideration of these issues, a survey has been created to analyze the variability among various clinician types (physicians, pharmacists, physician assistants, and nurse practitioners) in their calculations for five preselected opioids at fixed doses. The primary hypothesis is that there will be a statistically significant difference in average responses and ranges to these requested conversions. This was demonstrated on a small sample size of pharmacy interns from the Albany College of Pharmacy & Health Sciences.
We invite and encourage you to participate in this quest in which you will remain anonymous, to determine disparity and variability in opioid conversions among clinicians. Please help to dispel the myth that “all opioids are converted equally” and can easily be attributable to a “daily morphine equivalent” by clicking https://www.surveymonkey.com/
This project is being conducted in collaboration with the Albany College of Pharmacy & Health Sciences, University of Maryland School of Pharmacy, and Pharmacy Residents from the Stratton VA Medical Center in Albany NY.
This project is developed by Doctors Amanda Rennick (PGY1 Resident), Timothy John Atkinson (PGY2 Resident), and Nina Comino (PGY2 Resident) under the direction of Doctors Jeffrey Fudin and Mary Lynn McPherson.